Headlines
-
New IR reforms ‘counterproductive’
Monday | Dec 14 2020PHARMACY workers are being warned against signing up to new enterprise agreements if the Federal Government's Industrial Relations Omnibus Bill is passed.
-
No time to wait for naloxone funding
Monday | Dec 14 2020VICTORIAN MP, Dr Tim Read, is calling on the State Government to cover pharmacists' fees for the administration of opioid replacement therapies, including naloxone.
-
Cap Chemist celebrates
Monday | Dec 14 2020AS 2020 winds to a close, the Capital Chemist Group has celebrated the achievements of its pharmacies.
-
Back pharmacy to optimise COVAX
Friday | Dec 11 2020GOVERNMENTS around the globe are being urged to take advantage of the public trust in pharmacists to ensure optimal uptake of COVID-19 vaccines (COVAX).
-
Pharmacy wages stay static in 2020
Friday | Dec 11 2020DESPITE a "slight increase" in the Pharmacy Industry Award in Jul, wages across the sector have largely remained steady, the Raven's Recruitment Pharmacy Salary and Market Report 2020 reveals.
-
One pharmacy town set to lose store
Thursday | Dec 10 2020PATIENTS living in the rural Western Australian town of Mullewa will have to make a round trip of almost 200km to access medicines when the only pharmacy in the area closes next month.
-
Board changes rego exam format
Thursday | Dec 10 2020INTERN pharmacists taking their registration examination in 2021 will be the first to sit a new shorter format.
-
COVAX rollout no time for turf war
Wednesday | Dec 9 2020PLANS to authorise pharmacist immunisers to administer COVID-19 vaccines (COVAX) should not be used as part of an interprofessional turf war, Pharmaceutical Society of Australia (PSA) National President, Associate Professor Chris Freeman, believes.
-
Pharmacy prices expected to rise
Wednesday | Dec 9 2020ALMOST 60% of pharmacists who took part in the latest Attain Pharmacy Market Sentiment Survey expect pharmacy business prices to increase in 2021.
-
Hospitals key to take home naloxone
Wednesday | Dec 9 2020HOSPITAL pharmacies can play a critical part in identifying individuals at risk of opioid harm, who could benefit from access to take home naloxone, the Society of Hospital Pharmacists of Australia (SHPA) believes.
